Certara, a biosimulation technology-enabled drug development company, has merged its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, CA. The resulting organization, called Certara Strategic Consulting, expands Certara’s position in the growing modeling and simulation/pharmacometric services field, adding modeling capabilities, therapeutic areas of expertise, and new value-added services ...